Mettler-Toledo International, Inc. (NYSE:MTD) Receives Consensus Rating of “Moderate Buy” from Brokerages

Shares of Mettler-Toledo International, Inc. (NYSE:MTD) have been assigned a consensus rating of “Moderate Buy” from the ten ratings firms that are covering the company, MarketBeat.com reports. Five analysts have rated the stock with a hold recommendation and five have issued a buy recommendation on the company. The average 12-month target price among brokerages that have covered the stock in the last year is $1,311.1111.

A number of equities research analysts have weighed in on the stock. Jefferies Financial Group raised shares of Mettler-Toledo International from an “underperform” rating to a “hold” rating and cut their price target for the company from $1,200.00 to $1,110.00 in a report on Monday, May 5th. Wells Fargo & Company upped their price target on shares of Mettler-Toledo International from $1,125.00 to $1,200.00 and gave the company an “equal weight” rating in a report on Monday, May 5th. Evercore ISI cut their price target on shares of Mettler-Toledo International from $1,280.00 to $1,275.00 and set an “outperform” rating for the company in a report on Monday, August 4th. Barclays assumed coverage on shares of Mettler-Toledo International in a report on Tuesday, June 24th. They issued an “overweight” rating and a $1,325.00 price target for the company. Finally, Citigroup upped their price target on shares of Mettler-Toledo International from $1,400.00 to $1,600.00 and gave the company a “buy” rating in a report on Thursday, August 21st.

Mettler-Toledo International Stock Performance

NYSE:MTD opened at $1,285.99 on Thursday. The company has a market capitalization of $26.49 billion, a price-to-earnings ratio of 32.57, a price-to-earnings-growth ratio of 3.85 and a beta of 1.34. Mettler-Toledo International has a one year low of $946.69 and a one year high of $1,521.01. The stock has a 50-day simple moving average of $1,235.26 and a 200 day simple moving average of $1,187.41.

Mettler-Toledo International (NYSE:MTD) last posted its earnings results on Thursday, July 31st. The medical instruments supplier reported $10.09 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $9.58 by $0.51. The firm had revenue of $983.22 million during the quarter, compared to analyst estimates of $957.41 million. Mettler-Toledo International had a net margin of 21.46% and a negative return on equity of 476.07%. Mettler-Toledo International’s revenue was up 3.9% on a year-over-year basis. During the same period in the previous year, the business posted $9.65 EPS. Mettler-Toledo International has set its FY 2025 guidance at 42.100-42.600 EPS. Q3 2025 guidance at 10.550-10.750 EPS. On average, equities research analysts forecast that Mettler-Toledo International will post 42.71 EPS for the current fiscal year.

Insider Buying and Selling at Mettler-Toledo International

In other Mettler-Toledo International news, CFO Shawn Vadala sold 300 shares of the company’s stock in a transaction dated Tuesday, August 19th. The shares were sold at an average price of $1,325.00, for a total value of $397,500.00. Following the completion of the sale, the chief financial officer directly owned 5,095 shares of the company’s stock, valued at approximately $6,750,875. This represents a 5.56% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Gerry Keller sold 165 shares of Mettler-Toledo International stock in a transaction dated Thursday, August 14th. The stock was sold at an average price of $1,308.64, for a total value of $215,925.60. Following the completion of the transaction, the insider directly owned 94 shares in the company, valued at $123,012.16. This represents a 63.71% decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders sold 1,827 shares of company stock valued at $2,371,208. 1.94% of the stock is owned by insiders.

Hedge Funds Weigh In On Mettler-Toledo International

A number of institutional investors have recently bought and sold shares of the stock. Vanguard Group Inc. increased its stake in Mettler-Toledo International by 0.5% in the 2nd quarter. Vanguard Group Inc. now owns 2,556,707 shares of the medical instruments supplier’s stock worth $3,003,415,000 after purchasing an additional 13,342 shares in the last quarter. Bank of New York Mellon Corp increased its stake in Mettler-Toledo International by 71.3% in the 2nd quarter. Bank of New York Mellon Corp now owns 904,264 shares of the medical instruments supplier’s stock worth $1,062,257,000 after purchasing an additional 376,419 shares in the last quarter. Alliancebernstein L.P. increased its stake in Mettler-Toledo International by 1.1% in the 2nd quarter. Alliancebernstein L.P. now owns 717,449 shares of the medical instruments supplier’s stock worth $842,802,000 after purchasing an additional 8,121 shares in the last quarter. Geode Capital Management LLC increased its stake in Mettler-Toledo International by 0.6% in the 2nd quarter. Geode Capital Management LLC now owns 581,847 shares of the medical instruments supplier’s stock worth $681,489,000 after purchasing an additional 3,383 shares in the last quarter. Finally, Price T Rowe Associates Inc. MD increased its stake in Mettler-Toledo International by 5.5% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 481,011 shares of the medical instruments supplier’s stock worth $568,032,000 after purchasing an additional 25,272 shares in the last quarter. Hedge funds and other institutional investors own 95.07% of the company’s stock.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.